Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 9,502,000 | 5,203,000 | 6,528,000 | 7,989,000 | 11,969,000 |
Marketable Securities | 1,976,000 | 1,980,000 | 16,000 | 48,000 | 952,000 |
Receivables | 5,326,000 | 5,327,000 | 5,077,000 | 4,895,000 | 4,765,000 |
Inventories | 4,757,000 | 4,554,000 | 4,411,000 | 4,086,000 | 4,152,000 |
Other current assets | 2,501,000 | 2,258,000 | 2,488,000 | 2,367,000 | 2,542,000 |
TOTAL | $24,062,000 | $19,322,000 | $18,520,000 | $19,385,000 | $24,380,000 |
Non-Current Assets | |||||
PPE Net | 5,188,000 | 5,158,000 | 5,142,000 | 5,184,000 | 4,982,000 |
Intangibles | 28,111,000 | 28,792,000 | 29,464,000 | 30,072,000 | 29,324,000 |
Other Non-Current Assets | 6,339,000 | 6,022,000 | 6,070,000 | 6,524,000 | 6,307,000 |
TOTAL | $39,638,000 | $39,972,000 | $40,676,000 | $41,780,000 | $40,613,000 |
Total Assets | $63,700,000 | $59,294,000 | $59,196,000 | $61,165,000 | $64,993,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 1,543,000 | 817,000 | 844,000 | 87,000 | 4,288,000 |
Accounts payable and accrued liabilities | 1,204,000 | 1,256,000 | 1,403,000 | 1,366,000 | 1,171,000 |
Accrued Expenses | 11,584,000 | 10,545,000 | 10,639,000 | 10,731,000 | 9,383,000 |
TOTAL | $14,331,000 | $12,618,000 | $12,886,000 | $12,184,000 | $14,842,000 |
Non-Current Liabilities | |||||
Long Term Debt | 37,161,000 | 35,705,000 | 36,010,000 | 33,222,000 | 33,291,000 |
Other Non-Current Liabilities | 8,555,000 | 8,552,000 | 9,384,000 | 9,059,000 | 8,643,000 |
TOTAL | $45,716,000 | $44,257,000 | $45,394,000 | $42,281,000 | $41,934,000 |
Total Liabilities | $60,047,000 | $56,875,000 | $58,280,000 | $54,465,000 | $56,776,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 533,579 | 534,931 | 534,200 | 557,029 | 563,266 |
Common Shares | 32,371,000 | 31,343,000 | 31,247,000 | 32,096,000 | 31,989,000 |
Retained earnings | -28,066,000 | -28,252,000 | -29,568,000 | -24,600,000 | -22,964,000 |
Other shareholders' equity | -652,000 | -672,000 | -763,000 | -796,000 | -808,000 |
TOTAL | $3,653,000 | $2,419,000 | $916,000 | $6,700,000 | $8,217,000 |
Total Liabilities And Equity | $63,700,000 | $59,294,000 | $59,196,000 | $61,165,000 | $64,993,000 |